ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.


Overview | Financials
Company Name ORIC Pharmaceuticals, Inc.
Symbol ORIC
Currency USD
Price 7.23
Market Cap 487,463,229
Dividend Yield 0%
52-week-range 5.27 - 16.65
Industry Biotechnology
Sector Healthcare
CEO Dr. Jacob M. Chacko M.B.A., M.D.
Website https://www.oricpharma.com

An error occurred while fetching data.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the

Related Stocks

Apyx Medical Corporation logo

Apyx Medical Corporation


1.38 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.


0.719 USD

CorMedix Inc. logo

CorMedix Inc.


4.39 USD

Gamida Cell Ltd. logo

Gamida Cell Ltd.


0.033 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.


3.18 USD

Pieris Pharmaceuticals, Inc. logo

Pieris Pharmaceuticals, Inc.


9.09 USD

Genenta Science S.p.A. logo

Genenta Science S.p.A.


3.1 USD


Numbers are in millions USD

Numbers are in millions USD